Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Coagulopathies after Vaccination against SARS-CoV-2 May Be Derived from a Combined Effect of SARS-CoV-2 Spike Protein and Adenovirus Vector-Triggered Signaling Pathways

6 Oct 2021

Abstract excerpt

Novel coronavirus SARS-CoV-2 has resulted in a global pandemic with worldwide 6-digit infection rates and thousands of death tolls daily. Enormous efforts are undertaken to achieve high coverage of immunization to reach herd immunity in order to stop the spread of SARS-CoV-2 infection. Several SARS-CoV-2 vaccines based on mRNA, viral vectors, or inactivated SARS-CoV-2 virus have been approved and are being...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Heparin-Induced Thrombocytopenia and Thrombosis
Share to Platelet Disorders and Treatments
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34639132
DOI: 10.3390/ijms221910791

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Coagulopathies after Vaccination against SARS-CoV-2 May Be Derived from a Combined Effect of SARS-CoV-2 Spike Protein and Adenovirus Vector-Triggered Signaling PathwaysPMID 34639132Read ↗

“Vaccine-Induced Covid-19 Mimicry” Syndrome:Splice reactions within the SARS-CoV-2 Spike open reading frame result in Spike protein variants that may cause thromboembolic events in patients immunized with vector-based vaccinesSemantic proximity Read ↗

Effect of a COVID-19-Heterologous Vaccination Schedule on Haemostasis: A Subanalysis of the Phase 2, Multicentre, Randomised, Controlled CombiVacS StudySemantic proximity Read ↗

COVID-19 Vaccines and Thrombosis—Roadblock or Dead-End Street?Semantic proximity Read ↗

Arterial and Venous Thrombosis in COVID-19 Disease: From Molecular Pathway to Vaccine AdministrationSemantic proximity Read ↗

Relevance of the viral Spike protein/cellular Estrogen Receptor-α interaction for endothelial-based coagulopathy induced by SARS-CoV-2Semantic proximity Read ↗

Population-Wide Persistent Hemostatic Changes After Vaccination With ChAdOx1-SSemantic proximity Read ↗

Interrelationship between COVID-19 and coagulopathy: pathophysiological and clinical evidenceSemantic proximity Read ↗

SARS-CoV-2 Spike protein activates TMEM16F-mediated platelet pro-coagulant activitySemantic proximity Read ↗

Mechanisms of Immunothrombosis by SARS-CoV-2Semantic proximity Read ↗

SARS-CoV-2 Spike protein promotes vWF secretion and thrombosis via endothelial cytoskeleton-associated protein 4 (CKAP4)Semantic proximity Read ↗

SARS CoV-2 adenovirus and RNA based vaccines potential autoimmune complications: could we lower the chances?Semantic proximity Read ↗

Autoimmunity and Antibody Dependent COVID-19 Enhancement of SARS CoV-2 Vaccination: A Global Human Right to Know then Decide.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.